7Baggers
 Mainz Biomed to present at WEO CRC Screening Committee Meeting  TipRanks Tue, 30 Sep 2025 12:39:45 GMT
 Published on: 2025-09-30 00:50:22  newser.com Tue, 30 Sep 2025 05:50:22 GMT
 Mainz Biomed expands into Switzerland with labor team w  MSN Mon, 29 Sep 2025 10:42:35 GMT
 published on: 2025-09-28 00:58:03  newser.com Sun, 28 Sep 2025 05:58:03 GMT
 Mainz Biomed Reports Financial Results for First Half of 2025  TipRanks Fri, 26 Sep 2025 21:38:40 GMT
 Mainz Biomed Announces Commercial Launch of ColoAlert® in Switzerland  GlobeNewswire Tue, 23 Sep 2025 12:03:59 GMT
 mainz biomed files to sell 1.47m ordinary units  MSN Thu, 18 Sep 2025 23:37:48 GMT
 published on: 2025-09-16 00:55:23  خودرو بانک Mon, 15 Sep 2025 21:29:38 GMT
 Mainz Biomed Announces Registration of ColoAlert in the United Kingdom  GlobeNewswire Tue, 02 Sep 2025 07:00:00 GMT
 Mainz Biomed's ColoAlert® Receives MHRA Approval for UK Market Expansion  Quiver Quantitative Tue, 02 Sep 2025 07:00:00 GMT
 rockford register star: local news, politics & sports in rockford, il  FinancialContent Tue, 02 Sep 2025 07:00:00 GMT
 published on: 2025-09-02 08:05:38  خودرو بانک Tue, 02 Sep 2025 07:00:00 GMT
 published on: 2025-08-31 17:01:20  beatles.ru Sun, 31 Aug 2025 14:02:23 GMT

Mainz Biomed B.V.
(NASDAQ:MYNZ) 

MYNZ stock logo

Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic tests for clinical diagnostics in the area of human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a stool-based screening test for the detection of pancreatic cancer; GenoS...

Founded: 2008
Sector: Healthcare
Industry: Diagnostics & Research

Share this website to your friends